CoChat
Sign Up
Cited by 527

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcA

Lee, Matt K, Pardoux, Cécile, Hall, Marie C, Lee, Pierre S, Warburton, David, Qing, Jing, Smith, Susan M, Derynck, Rik·2007·The EMBO Journal
DOI 10.1038/sj.emboj.7601818
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.emboj.7601818

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dab2 modulates the non-canonical pathways of TGF-beta by suppressing Ras/MAPK activation.

    “Therefore, it was concluded that Dab2 modulates the non-canonical pathways of TGF-beta by suppressing Ras/MAPK activation”

    From Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice (2016) · cites this paper as Lee et al., 2007

    The Introduction and the section ‘Direct induction of MAP kinase by TGF-b is mediated by ShcA’ describe TGF-β-induced Ras/MAPK signaling and its attenuation by ShcA mutants. The passages provided and searches for Dab2 and Disabled-2 yielded no discussion of whether Dab2 suppresses that pathway, which is the claim attributed to this source. (LLM, conf=0.73)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 43

  1. Attisano L, Wrana JL (2002) Signal transduction by the TGF‐β superfamily. Science 296: 1646–1647 · DOI
  2. Berrou E, Fontenay‐Roupie M, Quarck R, McKenzie FR, Lévy‐Toldano S, Tobelem G, Bryckaert M (1996) Transforming growth factor β1 inhibits mitogen‐activated protein kinase induced by basic fibroblast growth factor in smooth muscle cells. Biochem J 316: 167–173 · DOI
  3. Cano E, Hazzalin CA, Kardalinou E, Buckle RS, Mahadevan LC (1995) Neither ERK nor JNK/SAPK MAP kinase subtypes are essential for histone H3/HMG‐14 phosphorylation or c‐fos and c‐jun induction. J Cell Sci 108: 3599–3609 · DOI
  4. Chen RH, Moses HL, Maruoka EM, Derynck R, Kawabata M (1995) Phosphorylation‐dependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor‐β receptors. J Biol Chem 270: 12235–12241 · DOI
  5. Cooper JA, Sefton BM, Hunter T (1983) Detection and quantification of phosphotyrosine in proteins. Methods Enzymol 99: 387–402 · DOI
  6. Davies M, Robinson M, Smith E, Huntley S, Prime S, Paterson I (2005) Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF‐β1 involves MAPK, Smad and AP‐1 signalling pathways. J Cell Biochem 95: 918–931 · DOI
  7. Derynck R, Zhang YE (2003) Smad‐dependent and Smad‐independent pathways in TGF‐β family signalling. Nature 425: 577–584 · DOI
  8. Feng XH, Derynck R (1996) Ligand‐independent activation of transforming growth factor (TGF) β signaling pathways by heteromeric cytoplasmic domains of TGF‐β receptors. J Biol Chem 271: 13123–13129 · DOI
  9. Feng XH, Filvaroff EH, Derynck R (1995) Transforming growth factor‐β (TGF‐β)‐induced down‐regulation of cyclin A expression requires a functional TGF‐β receptor complex. Characterization of chimeric and truncated type I and type II receptors. J Biol Chem 270: 24237–24245 · DOI
  10. Frippiat C, Chen QM, Zdanov S, Magalhäes JP, Remacle J, Toussaint O (2001) Subcytotoxic H2O2 stress triggers a release of transforming growth factor‐β1, which induces biomarkers of cellular senescence of human diploid fibroblasts. J Biol Chem 276: 2531–2537 · DOI
  11. Gotoh N, Muroya K, Hattori S, Nakamura S, Chida K, Shibuya M (1995) The SH2 domain of Shc suppresses EGF‐induced mitogenesis in a dominant negative manner. Oncogene 11: 2525–2533
  12. Gotoh N, Tojo A, Shibuya M (1996) A novel pathway from phosphorylation of tyrosine residues 239/240 of Shc, contributing to suppress apoptosis by IL‐3. EMBO J 15: 6197–6204 · DOI
  13. Hanks SK, Hunter T (1995) Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J 9: 576–596 · DOI
  14. Huse M, Chen YG, Massagué J, Kuriyan J (1999) Crystal structure of the cytoplasmic domain of the type I TGFβ receptor in complex with FKBP12. Cell 96: 425–436 · DOI
  15. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS (2002) SB‐431542 is a potent and specific inhibitor of transforming growth factor‐β superfamily type I activin receptor‐like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62: 65–74 · DOI
  16. Kavanaugh WM, Williams LT (1994) An alternative to SH2 domains for binding tyrosine‐phosphorylated proteins. Science 266: 1862–1865 · DOI
  17. Kisielow M, Kleiner S, Nagasawa M, Faisal A, Nagamine Y (2002) Isoform‐specific knockdown and expression of adaptor protein ShcA using small interfering RNA. Biochem J 363: 1–5 · DOI
  18. Kretzschmar M, Doody J, Timokhina I, Massagué J (1999) A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras. Genes Dev 13: 804–816 · DOI
  19. Lai KM, Pawson T (2000) The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo. Genes Dev 14: 1132–1145 · DOI
  20. Lawler S, Feng XH, Chen RH, Maruoka EM, Turck CW, Griswold‐Prenner I, Derynck R (1997) The type II transforming growth factor‐β receptor autophosphorylates not only on serine and threonine but also on tyrosine residues. J Biol Chem 272: 14850–14859 · DOI
  21. Lee MK, Zhao J, Smith S, Tefft JD, Bringas Jr P, Hwang C, Warburton D (1998) The Shc 66 and 46 kDa isoforms are differentially downregulated at parturition in the fetal mouse lung. Pediatr Res 44: 850–859 · DOI
  22. Lindberg RA, Quinn AM, Hunter T (1992) Dual‐specificity protein kinases: will any hydroxyl do? Trends Biochem Sci 17: 114–119 · DOI
  23. Lotti LV, Lanfrancone L, Migliaccio E, Zompetta C, Pelicci G, Salcini AE, Falini B, Pelicci PG, Torrisi MR (1996) Shc proteins are localized on endoplasmic reticulum membranes and are redistributed after tyrosine kinase receptor activation. Mol Cell Biol 16: 1946–1954 · DOI
  24. Luzi L, Confalonieri S, di Fiore PP, Pelicci PG (2000) Evolution of Shc functions from nematode to human. Curr Opin Genet Dev 10: 668–674 · DOI
  25. Lyons RM, Miller DA, Graycar JL, Moses HL, Derynck R (1991) Differential binding of transforming growth factor‐β1, ‐β2, and ‐β3 by fibroblasts and epithelial cells measured by affinity cross‐linking of cell surface receptors. Mol Endocrinol 5: 1887–1896 · DOI
  26. Macias‐Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL (1996) MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87: 1215–1224 · DOI
  27. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002) The protein kinase complement of the human genome. Science 298: 1912–1934 · DOI · Paper page
  28. Massagué J (2000) How cells read TGF‐β signals. Nat Rev Mol Cell Biol 1: 169–178 · DOI
  29. Migliaccio E, Mele S, Salcini AE, Pelicci G, Lai KM, Superti Furga G, Pawson T, di Fiore PP, Lanfrancone L, Pelicci PG (1997) Opposite effects of the p52Shc/p46Shc and p66Shc splicing isoforms on the EGF receptor‐MAP kinase‐fos signalling pathway. EMBO J 16: 706–716 · DOI
  30. Mucsi I, Skorecki KL, Goldberg HJ (1996) Extracellular signal‐regulated kinase and the small GTP‐binding protein, Rac, contribute to the effects of transforming growth factor‐β1 on gene expression. J Biol Chem 271: 16567–16572 · DOI
  31. Mulder KM (2000) Role of Ras and Mapks in TGFβ signaling. Cytokine Growth Factor Rev 11: 23–35 · DOI · Paper page
  32. Olsson N, Piek E, Sundstrom M, ten Dijke P, Nilsson G (2001) Transforming growth factor‐β‐mediated mast cell migration depends on mitogen‐activated protein kinase activity. Cell Signal 13: 483–490 · DOI
  33. Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G, Nicoletti I, Pawson T, Pelicci PG (1992) A novel transforming protein (Shc) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70: 93–104 · DOI
  34. Qi M, Elion EA (2005) MAP kinase pathways. J Cell Sci 118: 3569–3572 · DOI
  35. Ravichandran KS (2001) Signaling via Shc family adapter proteins. Oncogene 20: 6322–6330 · DOI
  36. Simeone DM, Zhang L, Graziano K, Nicke B, Pham T, Schaefer C, Logsdon CD (2001) Smad4 mediates activation of mitogen‐activated protein kinases by TGF‐β in pancreatic acinar cells. Am J Physiol Cell Physiol 281: C311–C319 · DOI
  37. Thomas D, Bradshaw RA (1997) Differential utilization of ShcA tyrosine residues and functional domains in the transduction of epidermal growth factor‐induced mitogen‐activated protein kinase activation in 293T cells and nerve growth factor‐induced neurite outgrowth in PC12 cells. Identification of a new Grb2‐2‐Sos1 binding site. J Biol Chem 272: 22293–22299 · DOI
  38. Trub T, Choi WE, Wolf G, Ottinger E, Chen Y, Weiss M, Shoelson SE (1995) Specificity of the PTB domain of Shc for β turn‐forming pentapeptide motifs amino‐terminal to phosphotyrosine. J Biol Chem 270: 18205–18208 · DOI
  39. van der Geer P, Wiley S, Gish GD, Pawson T (1996) The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein‐protein interactions. Curr Biol 6: 1435–1444 · DOI
  40. Ventura A, Maccarana M, Raker VA, Pelicci PG (2004) A cryptic targeting signal induces isoform‐specific localization of p46Shc to mitochondria. J Biol Chem 279: 2299–2306 · DOI
  41. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massagué J (1992) TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71: 1003–1014 · DOI
  42. Yamashita H, ten Dijke P, Franzen P, Miyazono K, Heldin CH (1994) Formation of hetero‐oligomeric complexes of type I and type II receptors for transforming growth factor‐β. J Biol Chem 269: 20172–20178 · DOI
  43. Yasuda K, Aoshiba K, Nagai A (2003) Transforming growth factor‐β promotes fibroblast apoptosis induced by H2O2. Exp Lung Res 29: 123–134 · DOI

Cited by

Sorted by citations

Metadata

Authors
Lee, M. K., Pardoux, C., Hall, M. C., Lee, P. S., Warburton, D., Qing, J., Smith, S. M., & Derynck, R.
Venue
The EMBO Journal
Publisher
Springer Science and Business Media LLC
Published
2007-08-02
Volume
26
Issue
17
Pages
3957-3967
ISSN
  • 0261-4189
  • 1460-2075
DOI
10.1038/sj.emboj.7601818
Cited by
527
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review